CorMedix, Inc. (CRMD)
7.785
+0.20
(+2.57%)
USD |
NASDAQ |
May 01, 16:00
7.78
0.00 (0.00%)
After-Hours: 20:00
CorMedix Shareholders Equity (Quarterly) : 405.31M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 86.48B |
| Altimmune, Inc. | 224.89M |
| Theravance Biopharma, Inc. | 296.72M |
| REGENXBIO, Inc. | 102.73M |
| Janux Therapeutics, Inc. | 956.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 877.63M |
| Total Liabilities (Quarterly) | 472.32M |
| Debt to Equity Ratio | 0.3674 |
| Current Ratio | 2.106 |
| Net Debt Paydown Yield | -3.22% |